Bottom Line<\/h3>\nFollowing their favorable Q2 reports now looks like a good time to buy Encompass Health and Vertex Pharmaceuticals stock. With price targets rising and earnings estimate revisions remaining higher their strong stock performances should continue as we progress through 2023.<\/p>\n
Vertex Pharmaceuticals Incorporated (VRTX): Free Stock Analysis Report<\/p>\n
Encompass Health Corporation (EHC): Free Stock Analysis Report<\/p>\n
Bristol Myers Squibb Company (BMY): Free Stock Analysis Report<\/p>\n
Pfizer Inc. (PFE): Free Stock Analysis Report<\/p>\n
To read this article on Zacks.com click here.<\/p>\n
Zacks Investment Research<\/p>\n
This article originally appeared on Zacks<\/i><\/p>\n
Sponsored: Find a Qualified Financial Advisor<\/b><\/p>\n
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.<\/p>\n
Source: Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"
Undoubtedly, healthcare stocks may be crossing investors\u2019 minds as many notable names like Pfizer (PFE), and Bristol Myers Squibb (BMY) continue to hover near 52-week […]<\/p>\n","protected":false},"author":3,"featured_media":133834,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"yoast_head":"\nHere’s Why Investors Should Buy These 2 Medical Stocks After Earnings - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/markets\/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Here’s Why Investors Should Buy These 2 Medical Stocks After Earnings - Fin2me\" \/>\n<meta property=\"og:description\" content=\"Undoubtedly, healthcare stocks may be crossing investors\u2019 minds as many notable names like Pfizer (PFE), and Bristol Myers Squibb (BMY) continue to hover near 52-week [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/markets\/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-03T17:39:10+00:00\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2023\/08\/Heres-Why-Investors-Should-Buy-These-2-Medical-Stocks-After-Earnings.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/markets\/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings\/\",\"url\":\"https:\/\/fin2me.com\/markets\/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings\/\",\"name\":\"Here’s Why Investors Should Buy These 2 Medical Stocks After Earnings - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2023-08-03T17:39:10+00:00\",\"dateModified\":\"2023-08-03T17:39:10+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/markets\/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/markets\/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/markets\/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Markets\",\"item\":\"https:\/\/fin2me.com\/category\/markets\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Here’s Why Investors Should Buy These 2 Medical Stocks After Earnings\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Here’s Why Investors Should Buy These 2 Medical Stocks After Earnings - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/markets\/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings\/","og_locale":"en_US","og_type":"article","og_title":"Here’s Why Investors Should Buy These 2 Medical Stocks After Earnings - Fin2me","og_description":"Undoubtedly, healthcare stocks may be crossing investors\u2019 minds as many notable names like Pfizer (PFE), and Bristol Myers Squibb (BMY) continue to hover near 52-week [...]","og_url":"https:\/\/fin2me.com\/markets\/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings\/","og_site_name":"Fin2me","article_published_time":"2023-08-03T17:39:10+00:00","author":"Mark","twitter_card":"summary_large_image","twitter_image":"https:\/\/fin2me.com\/wp-content\/uploads\/2023\/08\/Heres-Why-Investors-Should-Buy-These-2-Medical-Stocks-After-Earnings.jpg","twitter_misc":{"Written by":"Mark","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/markets\/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings\/","url":"https:\/\/fin2me.com\/markets\/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings\/","name":"Here’s Why Investors Should Buy These 2 Medical Stocks After Earnings - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2023-08-03T17:39:10+00:00","dateModified":"2023-08-03T17:39:10+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/markets\/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/markets\/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/markets\/heres-why-investors-should-buy-these-2-medical-stocks-after-earnings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Markets","item":"https:\/\/fin2me.com\/category\/markets\/"},{"@type":"ListItem","position":3,"name":"Here’s Why Investors Should Buy These 2 Medical Stocks After Earnings"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/133835"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=133835"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/133835\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media\/133834"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=133835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=133835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=133835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}